Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob J Malin

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 22, 2025
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination eraAnne Thierbach, Veronica Di Cristanziano, Kirsten A Eberhardt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
HIV Medicine|March 8, 2023
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIVJakob J Malin, Isabelle Suárez, Lena M Biehl, et al.
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
The Cochrane Database of Systematic Reviews|June 17, 2022
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Infection|November 3, 2020
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosisIsabelle Suárez, Samuel Rohr, Melanie Stecher, et al.
Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 22, 2025
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination eraAnne Thierbach, Veronica Di Cristanziano, Kirsten A Eberhardt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administrationSree Kurup, Nieves Velez de Mendizabal, Stephan Becker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
HIV Medicine|March 8, 2023
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIVJakob J Malin, Isabelle Suárez, Lena M Biehl, et al.
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
The Cochrane Database of Systematic Reviews|June 17, 2022
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Infection|November 3, 2020
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosisIsabelle Suárez, Samuel Rohr, Melanie Stecher, et al.
Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pageof 3